Durability of clinical benefit with TMS – 2010

Durability of clinical benefit with TMS PDF

By: Philip G. Janicak, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene M. Sampson, William M. McDonald, Lauren B. Marangell, Peter Rosenquist, W. Vaughn McCall, James Kimball, John P. O’Reardon, Colleen Loo, Mustafa H. Husain, Andrew Krystal, William Gilmer,
Sheila M. Dowd, Mark A. Demitrack, Alan F. Schatzberg

Although transcranial magnetic stimulation (TMS) can be an effective acute antidepressant treatment, few studies systematically examine persistence of benefit.

Related Posts